Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

FDA lifts clinical hold on DX-88 trials

June 10, 2004

Effect of peptide PYY on exocrine pancreatic function and gallbladder emptying

June 10, 2004

Glycogen synthase kinase 3 inhibitors function as insulin mimetics in vitro

June 10, 2004

Glucose-lowering effects of NHE-1 inhibitor CP-642353

June 10, 2004

Metabolic disease crosstalk and the potential role of PPAR agonists

June 9, 2004

Novel DPP-IV inhibitors in early development at BMS

June 9, 2004

Recombinant GAD65 shows promise in latent autoimmune diabetes in adults

June 9, 2004

Adenosine receptor antagonist improves insulin sensitivity

June 9, 2004

Investigations of olmesartan reported at ADA congress

June 9, 2004

Levemir receives European approval

June 9, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
Roche reports new TREM2 agonists
BioWorld Science
F. Hoffmann-la Roche Ltd. and Hoffmann-La Roche Inc. have identified new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for...
Genescience presents STAT6 degrader for atopic dermatitis
BioWorld Science
Genescience Pharmaceutical Co. Ltd. has presented data on a new STAT6 PROTAC degrader – GenSciP166 – which selectively targets STAT6 for proteasomal degradation....
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...